| scholarly article | Q13442814 |
| P50 | author | Ritushree Kukreti | Q87148604 |
| P2093 | author name string | Harpreet Kaur | |
| Sandeep Grover | |||
| Ajay Jajodia | |||
| Nidhi Agarwal | |||
| Ruchi Baghel | |||
| P2860 | cites work | The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis | Q21203801 |
| Predicting deleterious amino acid substitutions | Q22065761 | ||
| Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction | Q24320057 | ||
| Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis | Q24597718 | ||
| Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis | Q24600775 | ||
| Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor | Q24612437 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| Characterization of single-nucleotide polymorphisms in coding regions of human genes | Q28138557 | ||
| IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data | Q29043128 | ||
| Amino acid difference formula to help explain protein evolution | Q29614440 | ||
| Annotation of functional variation in personal genomes using RegulomeDB | Q29614867 | ||
| Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. | Q30436442 | ||
| Single nucleotide variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European population | Q33679056 | ||
| Novel neurotransmitters and their neuropsychiatric relevance | Q34073604 | ||
| A comparison of cataloged variation between International HapMap Consortium and 1000 Genomes Project data | Q34154307 | ||
| Cholecystokinin antagonists: pharmacological and therapeutic potential | Q34203535 | ||
| Trends in the exploitation of novel drug targets | Q34205159 | ||
| Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? | Q34275762 | ||
| Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans | Q34348095 | ||
| Drugs, their targets and the nature and number of drug targets | Q34571023 | ||
| Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort | Q34658720 | ||
| Genetic testing for pharmacogenetics and its clinical application in drug therapy | Q36242430 | ||
| AmpliChip CYP450 test: personalized medicine has arrived in psychiatry. | Q36481089 | ||
| Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge | Q36699480 | ||
| The pipeline and future of drug development in schizophrenia. | Q36898681 | ||
| Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study | Q36969067 | ||
| Addictions biology: haplotype-based analysis for 130 candidate genes on a single array | Q37300067 | ||
| Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. | Q37371260 | ||
| A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. | Q37536783 | ||
| Pharmacogenetics and pharmacogenomics: a clinical reality. | Q37898334 | ||
| What makes a good drug target? | Q37938432 | ||
| Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia | Q37945650 | ||
| Congruency in the prediction of pathogenic missense mutations: state-of-the-art web-based tools | Q38090602 | ||
| HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis | Q38171216 | ||
| Efficient genome-wide TagSNP selection across populations via the linkage disequilibrium criterion | Q38268750 | ||
| Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system | Q39721706 | ||
| Two faces of cholecystokinin: anxiety and schizophrenia | Q41061878 | ||
| A combined functional annotation score for non-synonymous variants | Q42227205 | ||
| Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. | Q42622876 | ||
| Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. | Q43227020 | ||
| The portability of tagSNPs across populations: a worldwide survey | Q43252157 | ||
| Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder | Q43722416 | ||
| Identification of neurotransmitter receptor genes under significantly relaxed selective constraint by orthologous gene comparisons between humans and rodents | Q44201813 | ||
| Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients | Q44406151 | ||
| Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients | Q44597660 | ||
| Trial watch: Phase II failures: 2008-2010. | Q44967713 | ||
| Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. | Q46006540 | ||
| Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder | Q46668190 | ||
| A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families | Q46801207 | ||
| An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. | Q48874030 | ||
| Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response. | Q51813520 | ||
| The Promise and Reality of Pharmacogenetics in Psychiatry | Q51846528 | ||
| A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients. | Q51864823 | ||
| Patterns of transitional mutation biases within and among mammalian genomes. | Q52950802 | ||
| Systematic investigation of genetic variability in 111 human genes-implications for studying variable drug response. | Q54672389 | ||
| Database resources of the National Center for Biotechnology Information | Q56337611 | ||
| Polymorphism discovery in 51 chemotherapy pathway genes | Q57275021 | ||
| P433 | issue | 12 | |
| P921 | main subject | pharmacogenomics | Q1152227 |
| P304 | page(s) | 1575-1587 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data | |
| P478 | volume | 15 |
| Q37030904 | Pathway Analyses Identify Novel Variants in the WNT Signaling Pathway Associated with Tuberculosis in Chinese Population | cites work | P2860 |
Search more.